Navigation Links
Uroplasty To Participate In Two Upcoming Investor Conferences
Date:11/6/2012

MINNEAPOLIS, Nov. 6, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in two upcoming investor conferences in November – the Stephens Fall Investment Conference and the Lazard 9th Annual Healthcare Conference. Detailed information is provided below:What:

Stephens Fall Investment ConferenceWhere:

New York Palace Hotel, New York, NYDate:

Tuesday, November 13, 2012Time:

4:00 pm ET 

What:

Lazard 9th Annual Healthcare ConferenceWhere:

Pierre Hotel, New York, NYDate:

Wednesday, November 14, 2012Time:

11:00 am ETDavid Kaysen, President and CEO, and Medi Jiwani, Chief Financial Officer, will discuss recent financial results and current corporate developments at both conferences.

Uroplasty will offer a live audio webcast of both events on the Company's website, www.uroplasty.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.uroplasty.com.

About Uroplasty, Inc.Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom is a global medical company committed to offering transformative treatment options to specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared system that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.For Further Information:Uroplasty, Inc.

EVC Group David Kaysen, President and CEO, or

Doug Sherk/Jenifer Kirtland (Investors), Medi Jiwani, Vice President, CFO, Treasurer

415.568.9349952.426.6140

Chris Gale (Media), 646.201.5431


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty to Present at the 11th Annual JMP Securities Research Conference
2. Uroplasty Announces Product Development and New Clinical Trial Initiatives
3. Uroplasty Reports Fiscal Fourth Quarter And Full Year 2012 Financial Results
4. Uroplasty To Present At The JMP Securities Healthcare Conference
5. Uroplasty to Issue First Quarter of Fiscal 2013 Financial Results on July 26, 2012
6. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
7. Uroplasty To Participate In Two Upcoming Conferences
8. Uroplasty Reports Fiscal Second Quarter 2013 Financial Results
9. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
10. Hill-Rom to Participate in the Deutsche Bank Securities Health Care Conference
11. Hill-Rom to Participate in the Bank of America Merrill Lynch 2012 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... Sapheneia and Scannerside received FDA 510(k) clearance ... a third-party Vendor neutral CT product that makes it ... with current MITA standards. ... is specifically designed to provide CT operators, prior to ... over a predefined threshold. Scannerside Dose Check is intended ...
(Date:9/5/2017)... Sept. 5, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral ... concluded its meeting with the U.S. Food and Drug ... formulation. At the ... pathway for submission of ORMD-0801, would be a Biologics ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology:
(Date:9/25/2017)... , ... September 25, 2017 , ... ... of the nationally syndicated The Sharon Kleyne Hour Power of Water, Global Climate ... us to shift our Olympic focus from a once-every-four-years series of events to ...
(Date:9/25/2017)... New York (PRWEB) , ... September 25, 2017 , ... ... due to severe Osteoarthritis and multiple health issues. As a cabaret and theater producer, ... walking as her main source of transportation in New York City, so she had ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... research, today announces that 30 of its domain experts will present on ... at upcoming industry conferences and webinars. Drawing on broad and deep industry ...
(Date:9/25/2017)... New Port Richey, FL (PRWEB) , ... September 25, 2017 , ... ... new New Port Richey, Fla. location at 5304 Main Street as an interventional pain ... pain of the spine and extremities. He joins PPOA from private practice In Brooksville, ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... is excited to announce the next generation for LASIK in Manhattan with Contoura ... the most technologically advanced laser systems available in the United States to correct ...
Breaking Medicine News(10 mins):